HYAL1 and breast carcinoma: Our finding that upregulation of HYAL1 in breast cancer cells could enhance the HAase activity significantly (Fig. 3A), and the HA expression was decreased obviously (Fig. 3A) in vitro, these results identified that HYAL1 could degrade HA.